Clinical Trials Browser

OTHER × Breast Neoplasms × Axitinib × Clear all

NCT05904730 2024-12-30

Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations

Phase 1 Completed

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms